OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	190,583	121,409	98,534	85,935	101,603	112,144
Market Cap Growth	74.79%	23.21%	14.66%	-15.42%	-9.40%	-19.02%
Enterprise Value	151,760	91,465	40,627	22,719	41,394	35,907
Last Close Price	10800.00	6880.00	6100.00	5320.00	6168.81	6533.49
PE Ratio	14.79	10.69	9.56	7.99	20.27	11.34
PS Ratio	2.19	1.39	1.20	1.19	1.73	1.96
PB Ratio	1.16	0.74	0.69	0.64	0.82	0.88
P/TBV Ratio	1.27	0.81	0.77	0.64	0.82	0.88
P/FCF Ratio	-	-	-	9.43	-	-
P/OCF Ratio	11.75	7.48	11.07	6.91	49.68	15.86
EV/Sales Ratio	1.74	1.05	0.50	0.31	0.71	0.63
EV/EBITDA Ratio	11.17	6.73	3.25	1.83	4.75	2.79
EV/EBIT Ratio	17.10	10.31	4.78	2.78	7.89	3.43
EV/FCF Ratio	-5.36	-	-	2.49	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.02	0.00
Debt / EBITDA Ratio	0.07	0.07	0.12	0.17	0.30	0.02
Debt / FCF Ratio	-	-	-	0.23	-	-
Net Debt / Equity Ratio	-0.23	-0.23	-0.35	-0.49	-0.47	-0.58
Net Debt / EBITDA Ratio	-2.86	-2.86	-4.00	-5.35	-6.77	-5.76
Net Debt / FCF Ratio	1.37	1.37	17.21	-7.29	14.91	20.89
Asset Turnover	0.49	0.49	0.52	0.51	0.43	0.43
Inventory Turnover	3.00	3.00	2.92	2.52	2.53	3.00
Quick Ratio	2.09	2.09	3.09	6.00	7.12	7.13
Current Ratio	2.62	2.62	3.69	7.02	8.34	8.00
Return on Equity (ROE)	7.36%	7.36%	7.41%	8.31%	3.99%	8.04%
Return on Assets (ROA)	3.10%	3.10%	3.37%	3.58%	2.38%	4.85%
Return on Invested Capital (ROIC)	7.20%	8.07%	8.97%	10.17%	6.52%	22.05%
Return on Capital Employed (ROCE)	5.40%	5.40%	5.90%	6.00%	4.20%	8.10%
Earnings Yield	5.96%	9.35%	10.46%	12.52%	4.93%	8.82%
FCF Yield	-14.84%	-23.30%	-2.95%	10.60%	-3.89%	-3.17%
Payout Ratio	-	-	14.80%	14.09%	32.01%	16.22%
Buyback Yield / Dilution	-1.88%	-1.88%	-0.53%	4.22%	1.07%	0.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.